Bisacurone inhibits adhesion of inflammatory monocytes or cancer cells to endothelial cells through down-regulation of VCAM-1 expressionDong‐Il Sun, Hye Jung Kim, Young‐Min Kim et al.|International Immunopharmacology|2008Cited by 52